Huebner Dirk 4
4 · Mersana Therapeutics, Inc. · Filed Dec 3, 2018
Insider Transaction Report
Form 4
Huebner Dirk
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-30+100,000→ 100,000 totalExercise: $5.30Exp: 2028-11-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on the first anniversary of the grant date and in equal quarterly installments over the next three years.